Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Stakeholders endorse UFS’s vision and strategy
2014-05-27

Results from a perception audit commissioned by the University of the Free State (UFS) in February 2014 have been finalised. The audit indicates that 86,14% of the university’s internal and external stakeholders agree with the institution's stated vision. An average of 81,99% of stakeholders endorse our values and 81,28% agree with our goals. 

The study was commissioned by the university's Department of Communication and Brand Management and conducted by an external firm of independent researchers. It was aimed at determining internal and external stakeholder understanding and endorsement of university strategy, as well as tracking core reputational indicators and perceptions.

The study was conducted among a representative sample of 23 stakeholder groupings, including staff, current and prospective students, donors, alumni, school principals, community leaders, potential employers of students and international partner universities.

Two similar audits were conducted in the last ten years – in 2005 and again in 2008 after the Reitz incident. Although a direct comparison of findings would not be psychometrically rigorous due to differing research modelling and sampling methods, there is a strong indication that the perception of the institution's stakeholders has shifted.

The uniqueness of the study and the research model developed for the project have recently received international recognition from the International Association of Business Communicators (IABC). The prestigious Jack Whittmer Research Award was presented to the university on 9 June 2014 during the Excellence Awards Gala of the association's world conference held in Toronto, Canada.

Read the full release (pdf)

 

 

Issued by: Lacea Loader (Director: Communication and Brand Management)
Tel: +27(0)51 401 2584 or +27(0)83 645 2454
E-mail: news@ufs.ac.za
Fax: +27(0)51 444 6393

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept